000 | 01149 a2200313 4500 | ||
---|---|---|---|
005 | 20250513225758.0 | ||
264 | 0 | _c20010125 | |
008 | 200101s 0 0 eng d | ||
022 | _a0924-8579 | ||
024 | 7 |
_a10.1016/s0924-8579(00)00299-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLivermore, D M | |
245 | 0 | 0 |
_aAntibiotic resistance in staphylococci. _h[electronic resource] |
260 |
_bInternational journal of antimicrobial agents _cNov 2000 |
||
300 |
_aS3-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aCoagulase _xdeficiency |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aGlycopeptides |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethicillin Resistance _xgenetics |
650 | 0 | 4 |
_aPenicillinase _xmetabolism |
650 | 0 | 4 |
_aPenicillins _xmetabolism |
650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 16 Suppl 1 _gp. S3-10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0924-8579(00)00299-5 _zAvailable from publisher's website |
999 |
_c11077481 _d11077481 |